IL111037A0 - Aspartoacylase gene, aspartoacylase polypeptides, process fot the preparation thereof and methods utilizing the same - Google Patents

Aspartoacylase gene, aspartoacylase polypeptides, process fot the preparation thereof and methods utilizing the same

Info

Publication number
IL111037A0
IL111037A0 IL11103794A IL11103794A IL111037A0 IL 111037 A0 IL111037 A0 IL 111037A0 IL 11103794 A IL11103794 A IL 11103794A IL 11103794 A IL11103794 A IL 11103794A IL 111037 A0 IL111037 A0 IL 111037A0
Authority
IL
Israel
Prior art keywords
aspartoacylase
polypeptides
preparation
same
methods utilizing
Prior art date
Application number
IL11103794A
Other versions
IL111037A (en
Original Assignee
Miami Childrens Hospital Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22433204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL111037(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miami Childrens Hospital Res filed Critical Miami Childrens Hospital Res
Priority to IL12592794A priority Critical patent/IL125927A/en
Priority to IL11212994A priority patent/IL112129A/en
Publication of IL111037A0 publication Critical patent/IL111037A0/en
Publication of IL111037A publication Critical patent/IL111037A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL111037A 1993-09-29 1994-09-22 Aspartoacylase gene, aspartoacylase polypeptides, processes for the preparation thereof and methods utilizing the same IL111037A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL12592794A IL125927A (en) 1994-09-22 1994-09-22 Evaporative media and a cooling tower utilizing same
IL11212994A IL112129A (en) 1993-12-23 1994-09-22 2,4-disulfo alpha-phenyl tertiary butyl nitrone its pharmaceutically acceptable salts and pharmaceutical compositions containing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12802093A 1993-09-29 1993-09-29
PCT/US1994/007430 WO1995009174A1 (en) 1993-09-29 1994-07-05 Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease

Publications (2)

Publication Number Publication Date
IL111037A0 true IL111037A0 (en) 1994-11-28
IL111037A IL111037A (en) 2006-06-11

Family

ID=22433204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL111037A IL111037A (en) 1993-09-29 1994-09-22 Aspartoacylase gene, aspartoacylase polypeptides, processes for the preparation thereof and methods utilizing the same

Country Status (5)

Country Link
US (3) US5679635A (en)
AU (1) AU7320794A (en)
CA (1) CA2172963C (en)
IL (1) IL111037A (en)
WO (1) WO1995009174A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2563643T3 (en) * 1997-04-01 2016-03-15 Illumina Cambridge Limited Nucleic acid sequencing method
WO1998046273A2 (en) * 1997-04-17 1998-10-22 Paola Leone Delivery system for gene therapy to the brain
US6423499B1 (en) * 1999-09-10 2002-07-23 The United States Of America, As Represented By The Secretary Of Agriculture PCR primers for detection and identification of plant pathogenic species, subspecies, and strains of acidovorax
US6593092B2 (en) 2000-04-04 2003-07-15 Abbott Laboratories Beta 2 adrenergic polymorphism detection
US7211381B1 (en) * 2000-04-04 2007-05-01 Abbott Laboratories β2 andrenergic polymorphism detection
US9182398B2 (en) 2006-04-01 2015-11-10 Medical Service Consultation International, Llc Methods and compositions for detecting fungi and mycotoxins
US20100068718A1 (en) 2008-08-22 2010-03-18 Hooper Dennis G Methods and Compositions for Identifying Yeast
US8962251B2 (en) 2009-10-08 2015-02-24 Medical Service Consultation International, Llc Methods and compositions for identifying sulfur and iron modifying bacteria
EP2534164A4 (en) * 2010-02-11 2013-09-11 Intelligent Med Devices Inc Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin
US9127321B2 (en) * 2010-10-06 2015-09-08 The Translational Genomics Research Institute Method of detecting Coccidioides species
EP3778887A3 (en) 2012-05-30 2021-04-07 Rowan University Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid
EP3474876A4 (en) * 2016-06-22 2020-01-15 City of Hope Treatment of canavan disease
RU2748289C1 (en) * 2020-07-17 2021-05-21 Акционерное общество "Центр Генетики и Репродуктивной Медицины "ГЕНЕТИКО" Canavan disease preimplantation genetic testing method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents

Also Published As

Publication number Publication date
US5679635A (en) 1997-10-21
US8669351B2 (en) 2014-03-11
US20030017473A1 (en) 2003-01-23
US7217547B2 (en) 2007-05-15
WO1995009174A1 (en) 1995-04-06
CA2172963A1 (en) 1995-04-06
IL111037A (en) 2006-06-11
AU7320794A (en) 1995-04-18
US20070026452A1 (en) 2007-02-01
CA2172963C (en) 2007-09-11

Similar Documents

Publication Publication Date Title
GB2278604B (en) Altered antibodies,products and processes relating thereto
EP0665590A3 (en) Microstructure, process for manufacturing thereof and devices incorporating the same.
EP0636879A3 (en) Biosensor and method for producing the same.
EP0643196A3 (en) Consolidatable particulate material and well treatment method.
EP0632099A3 (en) Organopolysiloxane and method for the preparation thereof.
AU7299796A (en) Cellulases, the genes encoding them and uses thereof
EP0630658A3 (en) Hyterosalpingography and selective salpingography.
IL133531A0 (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
EP0667541A3 (en) Optical functional materials and process for producing the same.
HUP9900339A3 (en) Water-soluble copolymers, process for producing the same and their use
EP0655625A3 (en) Sensing elements and method for making same.
EP0607597A3 (en) Marking composition, molding thereof and marking method.
EP0468464A3 (en) Cellulase, method for producing the same and use thereof
EP0657403A4 (en) Porous ceramic and process for producing the same.
EP0653392A4 (en) Porous ceramic and process for producing the same.
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
IL111037A0 (en) Aspartoacylase gene, aspartoacylase polypeptides, process fot the preparation thereof and methods utilizing the same
EP0635555A3 (en) Refining method and its configuration.
EP0684322A3 (en) Ceramic coating-forming agent and process for the production thereof.
EP0978524A4 (en) Fluoropolymer, process for preparing the same, and use thereof
EP0616988A3 (en) Ceramic composite and method.
EP0622369A3 (en) 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof.
ZA9410027B (en) Particulate explosive, manufacturing method and use.
EP0659779A3 (en) Microsphere and method for production thereof.
EP0669396A4 (en) Novel polypeptide and dna coding for the same.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired